Ten new dolabrane-type diterpenoids, notolutesins A−J (1−10), were isolated from the Chinese liverwort Notoscyphus lutescens, along with four known compounds. The structures of the new compounds were established on the basis of extensive spectroscopic data, and that of 1 was confirmed by single-crystal X-ray crystallography. The absolute configuration of 1 was determined by comparing its experimental and calculated electronic circular dichroism spectra. All of the isolates were evaluated for their cytotoxicity against a small panel of human cancer cell lines, and compound 1 exhibited an IC 50 value of 6.2 μM against the PC3 human prostate cancer cell line.
L iverworts (Hepaticae) are well known to produce lipophilic mono-, sesqui-, and diterpenoids, as well as aromatic compounds, of which many exhibit a variety of biological activities. 1 Species belonging to the family Jungermanniaceae are rich sources of labdane-, kaurane-, and clerodane-type diterpenoids. 2 Over the past few decades, chemical studies on the family Jungermanniaceae have focused mainly on the genus Jungermannia, 3, 4 while no phytochemical investigation has been reported on species of the genus Notoscyphus, due to difficulties concerning their collection and taxonomy.
In the course of an ongoing search for new bioactive substances from the Chinese liverworts, 5−9 the autochthonal liverwort Notoscyphus lutescens, collected from Mount Dawei, Yunnan Province, People's Republic of China, in April 2012, was investigated phytochemically. Ten new dolabrane-type diterpenoids, notolutesins A−J (1−10) , together with four known diterpenoids, ent-trans-communic acid, 10 ent-transcommunol, 11 15,16-bis-nor-13-oxo-8(17) ,11(E)-labdadien-18ol, 12 and (−)-pimara-9 (11) , 15-dien-19-ol, 13 were obtained. This is the first isolation of dolabrane-type diterpenoids from the family Jungermanniaceae. All of the structures were elucidated based on extensive spectroscopic data analyses, with single-crystal X-ray diffraction analysis performed to confirm the structure of 1. The cytotoxic activity of the isolated compounds was tested against five human cancer cell lines. Details of the isolation, structure elucidation, and cytotoxic activities of the compounds obtained are described herein.
■ RESULTS AND DISCUSSION
Notolutesin A (1) was obtained as colorless needles (CHCl 3 ). It gave a molecular formula of C 20 H 28 O 3 , as deduced from the pseudomolecular ion peak at m/z 334.2380 [M + NH 4 ] + (calcd 334.2377), requiring seven indices of hydrogen deficiency. The IR spectrum of 1 exhibited absorption bands at 3483 and 1758 cm −1 , accounting for the presence of OH and CO groups, respectively. The 1 H NMR spectrum ( Table 1) of 1 displayed resonances for two tertiary methyls [δ H 1.01 (s, H 3 -17) and 0.88 (s, H 3 -20) ], an oxygenated methylene [δ H 4.49 (d, J = 8.4 Hz, Ha-19) and 3.83 (d, J = 8.4 Hz, ], an oxygenated methine [δ H 4.45 (br t, H-2) ], a monosubstituted double bond [δ H 5.80 (dd, J = 17.4, 10.8 Hz, 4.93 (d, J = 17.4 Hz, , and 4.87 (d, J = 10.8 Hz, ], and an olefinic proton at δ H 6.85 (br s, H-3) . The 13 C NMR data (Table 3) and HSQC spectrum denoted the presence of 20 resonances for two methyls, seven sp 3 methylenes, of which one was oxygenated [δ C 78.8 (C-19) ], three sp 3 methines, of which one was oxygenated [δ C 65.0 (C-2)], three sp 3 quaternary carbons, four olefinic carbons [δ C 109.3 (C-16), 135.6 (C-4), 138.0 (C-3), and 150.7 (C-15) ], and one lactone carbonyl carbon [δ C 170.2 (C-18) ]. The aforementioned data indicated the characteristic of a dolabrane-type diterpenoid skeleton and a structure related to dolabradiene 14,15 for 1. The 1 H− 1 H COSY data ( Figure 1 ) of 1 revealed the presence of four isolated spin systems: C-10(H)−C-1(H 2 )−C-2(H)−C-3(H), C-6(H 2 )−C-7(H 2 )−C-8(H), C-11(H 2 )−C-12(H 2 ), and C-15(H)−C-16(H 2 ). On the basis of the HMBC correlations ( Figure 1 ) from H 2 -19 to C-4, C-5, C-6, and C-10, from H 3 -20 to C-8, C-9, C-10, and C-11, and from H 3 -17 to C-12, C-13, C-14, and C-15 , the 6/6/6 tricyclic core of the diterpenoid with 9,13dimethyl and 2-oxygenated substitutions could be elucidated. The γ-lactone ring was established from the HMBC correlations of H 2 -19/C-18 and H-3/C-18. Thus, the gross structure of 1 with a four-ring system was established.
The relative configurations of 1 were determined by analyzing its NOESY data ( Figure 2 ). NOE correlations of H-19b/H-10/H-8/H 3 -17 suggested that all of these are cofacial, and they were assigned arbitrarily as β-oriented. In addition, H- 6α and H-6β were determined by NOE correlations with H 3 -20 and H-19a, respectively . NOEs observed between H 3 -20 and H-2 supported the α-orientation of H-2. The conclusions stated above were confirmed by a single-crystal X-ray crystallography study ( Figure 3 ). Thus, the structure and relative configuration of 1 were elucidated as shown.
Notolutesin B (2) was assigned the molecular formula C 21 H 32 O 3 , based on its 13 C NMR data and HRESIMS, indicating the presence of one more carbon atom than 1, which was consistent with the presence of an additional oxygenated methyl [δ H 3.29 (s, H 3 -21) ; δ C 55.0 (C-21)] in 2. Furthermore, the 1 H and 13 C NMR data (Tables 1 and 3 ) Figure S21 , Supporting Information) from H 2 -21 to C-18 suggested that the methoxy group at C-18 in 2 is replaced by an ethoxy group in 3. Compounds 3 and 2 might be artifacts arising from compound 1 during the extraction and isolation in the presence of EtOH and MeOH, respectively. Thus, the structures of 2 and 3 were determined as depicted. Notolutesin D (4) was obtained as colorless needles (MeOH). A molecular formula of C 20 H 32 O was established on the basis of the 13 C NMR data and by HRESIMS, accounting for five indices of hydrogen deficiency. An examination of the 1 H and 13 C NMR data (Tables 1 and 3) showed the structure of 4 to be similar to that of 1. Further analysis of the NMR data of 4 indicated that the 18,19-lactone ring of 1 was absent. In contrast, an oxygenated methylene [δ H 4.10 (s, H 2 -18) ; δ C 63.1 (C-18)] and a tertiary methyl [δ H 1.09 (s, H 3 -19) ; δ C 22.2 (C-19)] could be located at C-4 and C-5, respectively, which were supported by HMBC correlations (Figure 1 ) from H 2 -18 to C-3 and C-5 and from H 3 -19 to C-4, C-5, C-6, and C-10, respectively. Key 1 H− 1 H COSY correlations (Figure 1 Figure S41 , Supporting Information). Thus, the structure of 5 was determined to be as depicted.
Compound 6 was assigned a molecular formula of C 19 H 26 O, based on its 13 C NMR data and HRESIMS, suggesting one additional index of hydrogen deficiency when compared to 5.
In the 1 H NMR spectrum, the olefinic protons at δ H 7.31 (d, J = 6.6 Hz, H-1), 7.20 (d, J = 7.8 Hz, H-2), and 7.24 (d, J = 6.6 Hz, H-3) underwent a large downfield shift, indicating the presence of a conjugated system. HMBC correlations ( Figure  S52 , Supporting Information) from H 2 -18 and H-3 to C-5 (δ C 138.8) and from H 3 -20 and H 2 -11 to C-10 (δ C 148.6) established that ring A formed an aromatic ring and the methyl group at C-19 was absent. Thus, 6 was assigned as a 19-nordolabrane diterpenoid, and its structure was determined as shown.
Notolutesin G (7) was isolated as a colorless oil. Its molecular formula was determined to be C 20 H 32 O 3 from the 13 C NMR and HRESIMS data, indicating the presence of two additional oxygen atoms when compared to 4. Comparison of the 1 H and 13 C NMR data (Tables 2 and 3) with those of 4 indicated that both compounds have an identical skeleton. However, their substituents were found to differ only in that C-2 (δ C 67.3) and C-19 (δ C 75.5) in 7 are oxygenated. The HMBC correlations ( Figure S63 2 -19 [δ H 3.35 (d, J = 6.6 Hz) and 2.90 (d, J = 6.6 Hz)] to C-4, C-5, C-6, and C-10 indicated the presence of OH groups at C-2 and C-19, respectively. NOE correlations of H 2 -19/H-10, H-10/H-8, and H-8/H 3 -17 supported these groups being βoriented. H-11α and H-11β were determined by NOEs with H 3 -20 and H 3 -17, respectively . Key NOE correlations of H-2 and H 3 -20 supported the β-orientation of OH-2 ( Figure S64 , Supporting Information). Thus, compound 7 was determined to be as shown.
Notolutesin H (8) was obtained as colorless crystals (CHCl 3 ), and its molecular formula, C 20 H 30 O 2 , was established from the HRESIMS and 13 C NMR data, suggesting one more index of hydrogen deficiency than 7. The 1 H and 13 C NMR data (Tables 2 and 3) of these two compounds were closely comparable, except that the oxymethylenes at C-4 and C-5 in 7 were replaced by an aldehyde [δ H 9.64 (s, H-18) ; δ C 194.9 (C-18)] and a tertiary methyl [δ H 1.28 (s, H 3 -19) ; δ C 34. 5 (C-19) ] in 8, respectively. The aldehyde group was assigned at C-4 due to the HMBC correlations ( Figure S74 , Supporting Information) from H-18 to C-3, C-4, and C-5. Similarly, HMBC correlations of H 3 -19/C-4, C-5, C-6, and C-10 confirmed the location of the methyl group (Me-19) at C-5. Thus, the structure of 8 was determined as depicted.
Notolutesin I (9) was assigned the molecular formula C 20 H 30 O 2 by its 13 C NMR data and from the HRESIMS. The 1 H and 13 C NMR data (Tables 2 and 3 ) were similar to those of 7, with the exception of the replacement of the hydroxy group at C-2 in 9 by a keto group [δ C 199.0 (C-2)] in 7. In addition, the presence of a hydroxy group at C-19 in 7 was methylated in 9. HMBC correlations ( Figure S85 , Supporting Information) were observed from H-10 and H 2 -18 to C-2 and from H 3 -19 to C-4, C-5, C-6, and C-10, respectively. Thus, the structure of compound 9 was determined as shown.
The molecular formula of notolutesin J (10) was determined to be C 20 H 30 O from the 13 C NMR data and by HRESIMS, suggesting one less oxygen atom present than in 9. Accordingly, the 1 H and 13 C NMR data ( Tables 2 and 3 ) of these compounds were closely comparable, except that the oxymethylene [δ H 4.39 (s, H 2 -18) and δ C 61.8 (C-18)] in 9 was found to be replaced by a tertiary methyl [δ H 1.06 (s, H 3 -18) and δ C 32.4 (C-18)] in 10, as confirmed by HMBC correlations (Figure S96 , Supporting Information) from H 3 -18 to C-3, C-4, and C-5. Thus, the structure of compound 10 was determined as shown.
The absolute configuration of compound 1 was established by comparing its experimental and calculated ECD spectra predicted by TDDFT (Experimental Section; Figure 4) . The results showed that the experimental and calculated ECD spectra were in good agreement. From the biosynthetic standpoint, the absolute configurations of compounds 2−10 were inferred as being the same as that of 1.
Four known diterpenoids, ent-trans-communic acid, 10 enttrans-communol, 11 15,16-bis-nor-13-oxo-8(17) ,11(E)-labdadien-18-ol, 12 and (−)-pimara-9(11), 15-dien-19-ol, 13 were also isolated. Their structures were identified by comparison with reported spectroscopic data.
The cytotoxicities of the isolated compounds were evaluated against PC3 and DU145 human prostate and H1688 and A549 human lung carcinoma cell lines, using the MTT method; 16 taxol and adriamycin were used as the positive controls. Only compound 1 showed cytotoxic activity against the PC3 cell line (IC 50 6.2 μM), but was inactive against the other three tested cell lines (IC 50 > 10 μM).
■ EXPERIMENTAL SECTION
General Experimental Procedures. Melting points were measured using an X-6 micromelting point apparatus (Tech Instrument Co., Ltd., Beijing, People's Republic of China) and are uncorrected. Optical rotations were obtained using a Gyromat-Hp polarimeter. UV spectra were acquired with an Agilent 8453E UV− visible spectroscopy system, with ECD spectra being obtained on a Chirascan spectropolarimeter (Applied Photophysics Ltd., Leatherhead, UK). IR spectra were recorded using a Nicolet iN 10 Micro FTIR spectrometer. NMR spectra were recorded on a Bruker Avance DRX-600 spectrometer operating at 600 ( 1 H) and 150 ( 13 C) MHz, with TMS as the internal standard. HRESIMS was performed on an LTQ-Orbitrap XL instrument. HPLC separations were performed on an Agilent 1200 G1311A quaternary pump equipped with an Agilent 1200 G1322A degasser, an Agilent 1200 G1329B 1260ALS, an Agilent 1200 G1315D DAD detector, and ZORBAX SB-C 18 15 and by scanning the potential energy surface on the main chain dihedral angles using the semiempirical AM1. The starting conformer of compound 1 came from the corresponding X-ray structure ( Figure  3 ). All ground-state geometries were optimized at the B3LYP/6-31G* level at 298 K, and harmonic frequency analysis was computed to confirm the minima and, hence, calculation of room-temperature free energy. Multiple low-energy conformations of compound 1 were found, and four lower energy conformations were selected to predict the ECD spectrum of the substance. Electronic excitation energies and rotational strengths in the gas phase and in methanol were calculated using TDDFT 19, 20 at the same level in the velocity formalism for the first 60 states. The solvent effect of MeOH has been modeled by a conductor-like screening model for real solvents (COSMO). 21, 22 The ECD curves were simulated by using the Gaussian function: 23 where σ is half the bandwidth at 1/e height and ΔE i and R i are the excitation energies and rotatory strengths for transition i, respectively. Here σ = 0.4 eV. Cytotoxicity Assays. The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5diphenyl-2H-tetrazolium bromide, Sigma] assay was used for the test compounds for cytotoxicity determination in 96-well plates. 16 The cells were plated in 96-well plates for 24 h prior to treatment and were exposed continuously to different concentrations of the compounds for 24 h. All of the samples for the cytotoxicity assays were dissolved in DMSO. Subsequently, 10 μL of MTT (5 mg/mL in phosphatebuffered saline) was added to each well, and the plates were incubated at 37°C under 5% CO 2 for 4 h. The absorbance of the solution was measured at 570 nm on a plate reader (Bio-Rad). IC 50 values (the concentration resulting in 50% inhibition of cell growth) for the test compounds were calculated from the plotted results, with untreated cells being set at 100%. The experiments were conducted a minimum of three times. Taxol and adriamycin were used as the positive controls, with IC 50 values of (0.94, 1.79, 0.85, and 1.04) and (11.74, 21.45, 4.22, and 23.71 ) against the PC3, DU145, H1688, and A549 cell lines, respectively. ■ ASSOCIATED CONTENT
